Skip to content
OpenCapital
Get started

Evolus EOLS Enterprise value

Enterprise value at other companies

AbbVie logo
AbbVieABBV
$460.96B+24.7%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×—
Current ratio2×-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

$267.4Mmarket cap+$164.9Mtotal debt−$49.8Mcash and equivalents=$382.51M

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's enterprise value?
Evolus (EOLS) reported enterprise value of $382.51M in Q1 2026.
How has Evolus's enterprise value changed year-over-year?
Evolus's enterprise value decreased by 56.0% year-over-year, from $868.92M to $382.51M.
What is the long-term trend for Evolus's enterprise value?
Over 5 years (2020 to 2025), Evolus's enterprise value has grown at a 43.2% compound annual growth rate (CAGR), from $88.54M to $532.22M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.